Patents by Inventor Bernard Ferrari

Bernard Ferrari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
    Patent number: 7157454
    Abstract: The invention relates to compounds of formula: These compounds show affinity for the bradykinin receptors with selectivity towards the B1 receptors; they may be used for the preparation of medicinal products intended for treating or preventing inflammation pathologies and persistent or chronic inflammatory diseases.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: January 2, 2007
    Assignee: Sanofi-Aventis
    Inventors: Bernard Ferrari, Jean Gougat, Yvette Muneaux, Pierre Perreaut, Lionel Sarran
  • Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
    Publication number: 20040116353
    Abstract: The invention relates to compounds of formula: 1
    Type: Application
    Filed: September 18, 2003
    Publication date: June 17, 2004
    Inventors: Bernard Ferrari, Jean Gougat, Yvette Muneaux, Pierre Perreaut, Lionel Sarran
  • N-(arylsulphonyl) amino acid derivatives
    Patent number: 6610882
    Abstract: The invention relates to compounds of formula in which R1 to R9, R16 and R17 are as defined in claim 1. These compounds are pharmacologically active.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: August 26, 2003
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Publication number: 20030073641
    Abstract: The invention relates to compounds of formula 1
    Type: Application
    Filed: June 7, 2002
    Publication date: April 17, 2003
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Publication number: 20020115685
    Abstract: The invention relates to compounds of formula 1
    Type: Application
    Filed: September 6, 2001
    Publication date: August 22, 2002
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Patent number: 6433185
    Abstract: The invention relates to compounds of formula in which R1 to R9, R16 and R17 are as defined in claim 1. These compounds are pharmacologically active.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: August 13, 2002
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • N-(arylsulfonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Patent number: 6313120
    Abstract: The invention relates to compounds of formula in which R1 to R9, R16 and R17 are as defined in Claim 1. These compounds are pharmacologically active.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: November 6, 2001
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Patent number: 6100278
    Abstract: The invention relates compounds of formula ##STR1## in which R.sub.1 to R.sub.9, R.sub.16 and R.sub.17 are as defined in claim 1.These compounds are pharmacologically active.
    Type: Grant
    Filed: November 4, 1999
    Date of Patent: August 8, 2000
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • N-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity
    Patent number: 6015812
    Abstract: The invention relates to compounds of formula ##STR1## in which R.sub.1 to R.sub.9, R.sub.16 and R.sub.17 are defined in claim 1. These compounds are pharmacologically active.
    Type: Grant
    Filed: July 2, 1998
    Date of Patent: January 18, 2000
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • Imidazolines
    Patent number: 5543528
    Abstract: The invention relates to compounds of the formula ##STR1## in which: R.sub.1 -R.sub.5 are defined in the specification, which are useful as angiotensin II antagonists.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: August 6, 1996
    Assignee: Sanofi
    Inventors: Bernard Ferrari, J elle Taillades, born Arnaud
  • Imidazolines N-substituted by a biphenylmethyl group, their medical use and the pharmaceutical compositions therefor
    Patent number: 5434167
    Abstract: The invention relates to compounds of the formula ##STR1## in which X and R.sub.1 -R.sub.5 are defined in the specification and their salts where appropriate, all of which are useful as angiotensin II antagonists.
    Type: Grant
    Filed: March 18, 1993
    Date of Patent: July 18, 1995
    Assignee: Sanofi
    Inventors: Bernard Ferrari, Joelle Taillades
  • N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders
    Patent number: 5274104
    Abstract: The present invention relates to N-substituted heterocyclic derivatives of formula: ##STR1## processes for their preparation, and pharmaceutical compositions which contain them. The compounds according to the invention are non-peptide compounds which oppose the action of angiotensin II. The compounds according to the invention are thus useful in the treatment of cardiovascular disorders such as hypertension and heart failure.
    Type: Grant
    Filed: June 19, 1992
    Date of Patent: December 28, 1993
    Assignee: Elf Sanofi, A French Corp.
    Inventors: Joelle Arnaud, Jean-Louis Assens, Claude Bernhart, Bernard Ferrari, Frederique Haudricourt, Pierre Perreaut
  • Dinitrogen heterocyclic derivatives N-substituted by a biphenylmethyl group, and the pharmaceutical compositions in which they are present
    Patent number: 5268375
    Abstract: This invention relates to compounds of formula ##STR1## in which: R.sub.1 and R.sub.2 are similar or different and are each independently hydrogen or a group selected from CO.sub.2 N.dbd.C(NH.sub.2).sub.2, CONHNHCONH.sub.2, CONHNHCSNH.sub.2, C(OC.sub.2 H.sub.5).dbd.NCO.sub.2 CH.sub.3, COCH.sub.2 CO.sub.2 H.sub.5, N(OH)-CONHCOOC.sub.2 NCO.sub.2 CH.sub.3, COCH.sub.2 CO.sub.2 H.sub.5, N(OH)-CONHCOOC.sub.2 H.sub.5, C(OC.sub.2 H.sub.5).dbd.NH or a nitrogen heterocycle; with the proviso that at least one of the substituents R.sub.1 or R.sub.2 is other than hydrogen;R.sub.3 is a hydrogen, a C.sub.1 -C.sub.6 alkyl, a C.sub.2 -C.sub.6 alkenyl, a C.sub.3 -C.sub.7 cycloalkyl, a phenyl, a phenylalkyl, or a phenylalkenyl;R.sub.4 and R.sub.5 are each independently a C.sub.1 -C.sub.6 alkyl, a C.sub.3 -C.sub.7 cycloalkyl, a phenyl or a phenylalkyl; orR.sub.4 and R.sub.5, bonded together, are either a group of the formula (CH.sub.2).sub.n or a group of the formula (CH.sub.2).sub.p Y (CH.sub.2).sub.
    Type: Grant
    Filed: February 28, 1992
    Date of Patent: December 7, 1993
    Assignee: Elf Sanofi
    Inventors: Claude Bernhart, Bernard Ferrari, Pierre Perreaut